Vital Farms, Inc.
VITL Nasdaq Food And Kindred Products Financials FY2018–FY2025
Last close · Oct 23, 2026
$9.14
2.9%What Vital Farms, Inc. does
No business description yet.
- Legal name
- Vital Farms, Inc.
- Fiscal year ends
- December 28, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Accession · CIK
- 0001193125-26-073423
0001579733
Revenue and margins
Vital Farms, Inc. had $759M of revenue in fiscal 2025, up 25.3% on the year before.
Net income and earnings per share
From fiscal 2018 to 2025, diluted EPS grew 36.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$48.2M in fiscal 2025, −6.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vital Farms, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 2.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Vital Farms, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $31.0M | $12.9M | $84.1M | $151M | $48.8M |
| Debt incl. finance leases | — | — | — | — | $10.8M |
| Net debt / EBITDA | — | — | — | — | −0.4x |
| Debt / equity | — | — | — | — | 0.0x |
| Interest coverage | 1.0x | 18.5x | 42.5x | 62.9x | 101.1x |
| Current ratio | 3.7x | 3.1x | 3.0x | 3.1x | 2.2x |
| Quick ratio | 3.4x | 2.6x | 2.5x | 2.8x | 1.6x |
| Total assets | $190M | $215M | $275M | $359M | $519M |
| Total liabilities | $38.2M | $56.3M | $82.5M | $90.0M | $167M |
| Shareholders' equity | $152M | $158M | $193M | $269M | $351M |
| Net debt (− = net cash) | — | — | — | — | −$38.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | — | — | — | — |
| Current ratio rose | — | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ |
| Revenue rose relative to assets | — | — | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ |
| F-score | — / 3 | — / 5 | 7 / 8 | 4 / 8 | 2 / 8 | 7 / 8 | 6 / 8 | 2 / 8 |
| Accruals ratio | — | 12.5% | −2.3% | −8.4% | 4.6% | −10.3% | −3.6% | 7.4% |
| Altman Z'' | — | 1.96 | 10.16 | 7.79 | 6.20 | 6.72 | 8.14 | 6.07 |
8 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $107M | $141M | $214M | $261M | $362M | $472M | $606M | $759M |
| Gross profit | $34.8M | $42.9M | $74.5M | $82.9M | $109M | $162M | $230M | $286M |
| Operating income | $6.8M | $3.4M | $12.2M | $0.1M | $2.1M | $33.3M | $63.6M | $88.4M |
| Interest expense | $0.4M | $0.3M | $0.5M | $0.1M | $0.1M | $0.8M | $1.0M | $0.9M |
| Pretax income | $6.4M | $4.4M | $11.7M | $0.4M | $2.8M | $32.2M | $67.5M | $91.3M |
| Income tax | $0.7M | $1.1M | $2.8M | −$2.0M | $1.6M | $6.6M | $14.2M | $25.0M |
| Net income | $5.8M | $2.4M | $8.8M | $2.4M | $1.3M | $25.6M | $53.4M | $66.3M |
| Diluted EPS | $0.16 | $0.07 | $0.27 | $0.06 | $0.03 | $0.59 | $1.18 | $1.44 |
| Diluted shares | 0.04B | 0.04B | 0.03B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B |
| Cash flow | ||||||||
| Cash from operations | $11.4M | −$5.4M | $11.5M | $17.7M | −$8.1M | $50.9M | $64.8M | $33.7M |
| Capital expenditure | $1.9M | $4.8M | $10.3M | $16.7M | $10.5M | $11.5M | $28.6M | $82.0M |
| Free cash flow | $9.5M | −$10.2M | $1.2M | $1.0M | −$18.6M | $39.4M | $36.2M | −$48.2M |
| Depreciation and amortization | $1.4M | $1.9M | $2.6M | $3.5M | $5.4M | $7.9M | $9.3M | $9.3M |
| Stock-based compensation | $0.6M | $1.0M | $2.5M | $4.4M | $6.0M | $7.4M | $10.3M | $12.4M |
| Share buybacks | — | $14.3M | — | — | — | — | — | — |
| Dividends and buybacks | — | $14.3M | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash and short-term investments | — | $1.3M | $29.5M | $31.0M | $12.9M | $84.1M | $151M | $48.8M |
| Total debt | — | $5.1M | — | — | — | — | — | $0.0M |
| Finance lease liabilities | — | — | — | $0.3M | $8.6M | $13.7M | $11.9M | $10.8M |
| Current assets | — | $34.7M | $137M | $141M | $150M | $196M | $246M | $263M |
| Current liabilities | — | $25.0M | $25.9M | $38.0M | $47.7M | $65.2M | $78.5M | $122M |
| Inventory | — | $12.9M | $12.9M | $10.9M | $26.8M | $32.9M | $23.7M | $66.5M |
| Property and equipment, net | — | $22.5M | $30.1M | $44.6M | $59.2M | $66.8M | $84.5M | $161M |
| Goodwill | — | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M |
| Total assets | — | $61.9M | $171M | $190M | $215M | $275M | $359M | $519M |
| Total liabilities | — | $30.1M | $29.0M | $38.2M | $56.3M | $82.5M | $90.0M | $167M |
| Preferred stock | — | — | — | — | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $4.3M | $8.6M | $142M | $152M | $158M | $193M | $269M | $351M |
| Margins | ||||||||
| Gross margin | 32.6% | 30.5% | 34.8% | 31.8% | 30.2% | 34.4% | 37.9% | 37.6% |
| Operating margin | 6.3% | 2.4% | 5.7% | 0.0% | 0.6% | 7.0% | 10.5% | 11.6% |
| EBITDA margin | 7.7% | 3.7% | 6.9% | 1.4% | 2.1% | 8.7% | 12.0% | 12.9% |
| Net margin | 5.4% | 1.7% | 4.1% | 0.9% | 0.3% | 5.4% | 8.8% | 8.7% |
| FCF margin | 8.9% | −7.2% | 0.6% | 0.4% | −5.1% | 8.3% | 6.0% | −6.4% |
| Returns | ||||||||
| Return on capital | — | 20.3% | — | — | — | — | — | 21.2% |
| Return on capital employed | — | 9.1% | 8.4% | 0.0% | 1.3% | 15.8% | 22.6% | 22.3% |
| Return on equity | 135.9% | 37.2% | 11.7% | 1.7% | 0.8% | 14.6% | 23.1% | 21.4% |
| Return on assets | — | 3.9% | 7.5% | 1.3% | 0.6% | 10.4% | 16.8% | 15.1% |
| Return on tangible equity | 135.9% | 50.7% | 6.4% | 1.6% | 0.8% | 13.5% | 20.1% | 19.1% |
| Growth | ||||||||
| Revenue growth | — | 31.9% | 52.3% | 21.8% | 38.8% | 30.3% | 28.5% | 25.3% |
| Net income growth | — | −58.9% | 269.0% | −72.4% | −48.5% | 1,943.6% | 108.8% | 24.2% |
| EPS growth | — | −56.3% | 285.7% | −77.8% | −50.0% | 1,866.7% | 100.0% | 22.0% |
| FCF growth | — | −207.0% | — | −19.9% | −2,012.0% | — | −8.1% | −233.3% |
| Share count change | — | 2.3% | −8.8% | 31.6% | 0.3% | −0.4% | 4.2% | 2.0% |
| Financial health | ||||||||
| Net debt / EBITDA | — | 0.7x | — | — | — | — | — | −0.4x |
| Debt / equity | — | 0.6x | — | — | — | — | — | 0.0x |
| Interest coverage | 16.0x | 9.6x | 25.1x | 1.0x | 18.5x | 42.5x | 62.9x | 101.1x |
| Current ratio | — | 1.4x | 5.3x | 3.7x | 3.1x | 3.0x | 3.1x | 2.2x |
| Quick ratio | — | 0.9x | 4.8x | 3.4x | 2.6x | 2.5x | 2.8x | 1.6x |
| Capital allocation | ||||||||
| Capex / revenue | 1.8% | 3.4% | 4.8% | 6.4% | 2.9% | 2.4% | 4.7% | 10.8% |
| Stock comp / revenue | 0.6% | 0.7% | 1.2% | 1.7% | 1.7% | 1.6% | 1.7% | 1.6% |
| Quality scores | ||||||||
| Piotroski F-score | — | — | 7.0 | 4.0 | 2.0 | 7.0 | 6.0 | 2.0 |
| Altman Z'' | — | 2.0 | 10.2 | 7.8 | 6.2 | 6.7 | 8.1 | 6.1 |
| Accruals ratio | — | 12.5% | −2.3% | −8.4% | 4.6% | −10.3% | −3.6% | 7.4% |
Source: SEC EDGAR XBRL filings (CIK 0001579733). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
